The use of proteasome inhibitors in anti-cancer therapy
<p>Proteins are the basic building blocks of the human body. Most proteins, after fulfilling their function, are degraded with the help of a multi-catalytic proteolytic complex - the 26S proteasome, thanks to its prior labeling with a poly-ubiquitin chain. The ubiquitin-proteasome complex is i...
Main Authors: | Marzena Teresa Baran, Paulina Miziak, Katarzyna Bonio |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazimierz Wielki University
2020-07-01
|
Series: | Journal of Education, Health and Sport |
Subjects: | |
Online Access: | https://apcz.umk.pl/czasopisma/index.php/JEHS/article/view/30827 |
Similar Items
-
New Scaffolds of Proteasome Inhibitors: Boosting Anticancer Potential by Exploiting the Synergy of In Silico and In Vitro Methodologies
by: Romina A. Guedes, et al.
Published: (2023-08-01) -
Ubiquitin–proteasome system and the role of its inhibitors in cancer therapy
by: Fatemeh Aliabadi, et al.
Published: (2021-04-01) -
Postmortem Degradation of Qinchuan Beef Protein by Proteasome and Its Mediated Ubiquitin-Proteasome Pathway
by: HU Lijun, ZHANG Qian, CHEN Xueyan, WANG Jinxia, LI Rong, LI Yalei, LUO Ruiming
Published: (2023-12-01) -
The ubiquitin-proteasome system in glioma cell cycle control
by: Vlachostergios Panagiotis J, et al.
Published: (2012-07-01) -
Evolution of Natural Product Scaffolds as Potential Proteasome Inhibitors in Developing Cancer Therapeutics
by: Reyaz Hassan Mir, et al.
Published: (2023-03-01)